Squarepoint’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Squarepoint’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12,952	Closed	-$389K	–	4644
2026 Q1	$389K	Buy	+12,952	New	+$429K	﹤0.01%	3510
2025 Q4	–	Sell	-6,099	Closed	-$211K	–	4491
2025 Q3	$211K	Buy	+6,099	New	+$195K	﹤0.01%	3906
2025 Q2	–	Sell	-8,154	Closed	-$205K	–	4691
2025 Q1	$205K	Buy	+8,154	New	+$206K	﹤0.01%	4001
2023 Q2	–	Sell	-18,251	Closed	-$705K	–	3719
2023 Q1	$705K	Buy	+18,251	New	+$750K	﹤0.01%	2110
2019 Q2	–	Sell	-8,863	Closed	-$1.04M	–	2482
2019 Q1	$1.04M	Buy	+8,863	New	+$894K	0.01%	1087
2018 Q4	–	Sell	-7,814	Closed	-$879K	–	2050
2018 Q3	$879K	Sell	7,814 -4,644	-37%	-$491K	0.01%	1052
2018 Q2	$1.15M	Buy	12,458 +2,258	+22%	+$219K	0.02%	843
2018 Q1	$1.02M	Buy	+10,200	New	+$1.1M	0.02%	807

Other funds holding LKFT

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

DCM

DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Squarepoint's LKFT Position: Q2 2026 in Review

Squarepoint sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2026, closing a stake of 12,952 shares — an estimated $389K sold.

Squarepoint first reported a position in LKFT in Q1 2018 and held it in 8 quarters. The position peaked at $1.15M in Q2 2018. 76 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

Squarepoint reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2026 after selling out during the quarter.
Squarepoint sold 12,952 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $389K.
Squarepoint first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2018 and held it in 8 quarters.
Squarepoint's Lakefront Biotherapeutics American Depositary Shares position peaked at $1.15M in Q2 2018.
76 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.